Red Crane Wealth Management, LLC Lineage Cell Therapeutics, Inc. Transaction History
Red Crane Wealth Management, LLC
- $104 Billion
- Q1 2025
A detailed history of Red Crane Wealth Management, LLC transactions in Lineage Cell Therapeutics, Inc. stock. As of the latest transaction made, Red Crane Wealth Management, LLC holds 495,996 shares of LCTX stock, worth $327,357. This represents 0.21% of its overall portfolio holdings.
Number of Shares
495,996
Previous 340,236
45.78%
Holding current value
$327,357
Previous $171 Million
31.01%
% of portfolio
0.21%
Previous 0.16%
Shares
2 transactions
Others Institutions Holding LCTX
# of Institutions
138Shares Held
108MCall Options Held
8KPut Options Held
3K-
Broadwood Capital Inc New York, NY49.6MShares$32.7 Million1.86% of portfolio
-
Black Rock Inc. New York, NY9.56MShares$6.31 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.92MShares$5.89 Million0.0% of portfolio
-
Defender Capital, Llc.6.31MShares$4.17 Million1.19% of portfolio
-
Raffles Associates LP New York, NY5.64MShares$3.72 Million3.45% of portfolio
About Lineage Cell Therapeutics, Inc.
- Ticker LCTX
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 169,755,008
- Market Cap $112M
- Description
- Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-re...